Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vaccitech plc - American Depositary Shares (NQ:VACC)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.950 (1)
Ask (Size) 5.180 (5)
Prev. Close 5.000
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 38,565,272
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
From Barinthus Biotherapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga

Performance

More News

Read More
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Via InvestorPlace
News headline image
Analyst Expectations for Vaccitech's Future ↗
Via Benzinga
News headline image
Vaccitech: Q1 Earnings Insights ↗
Via Benzinga
News headline image
Vaccitech Earnings Perspective: Return On Capital Employed ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗
Via Benzinga
News headline image
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise
Via FinancialNewsMedia
News headline image
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
From Vaccitech plc
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
Via Benzinga
News headline image
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
From Vaccitech plc
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
News headline image
Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal Antibody
From Arbutus Biopharma Corporation
Via GlobeNewswire
News headline image
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
From Vaccitech plc
Via GlobeNewswire
News headline image
Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying ↗
Via Benzinga
News headline image
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
From Vaccitech plc
Via GlobeNewswire
News headline image
7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗
Via InvestorPlace
News headline image
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Via Benzinga

Frequently Asked Questions

Is Vaccitech plc - American Depositary Shares publicly traded?
Yes, Vaccitech plc - American Depositary Shares is publicly traded.
What exchange does Vaccitech plc - American Depositary Shares trade on?
Vaccitech plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Vaccitech plc - American Depositary Shares?
The ticker symbol for Vaccitech plc - American Depositary Shares is VACC on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.